Extracorporeal Membrane Oxygenation (ECMO) is a vital tool
for healthcare providers in critical care medicine. When a person’s heart and
lungs are compromised, ECMO is the process by which un-oxygenated blood is
pumped to a heart and lung machine, reoxygenated and returned to the body
(known as the ECMO “circuit”). This bypasses the heart and lungs and allows
them to heal from a critical injury or illness. In addition to the risks of
hospital acquired infection (HAI) associated with being inpatient, ECMO patients
face an increased risk to the cannulation process used to create the circuit. Approximately
10-12% of those who receive ECMO experience a HAI and among those, the risk of
mortality is 38-63%.
Patients Who are at Greater Risks
- Older
Adults
- Pre-morbid
disease of the immune system
- Longer
ECMO treatment
- Central
instead of peripheral cannulation
- Surgical
instead of percutaneous cannulation
Prevention:
- Follow
standard guidelines for prevention of ventilator associated pneumonia by
elevating the head of the bed and proper pulmonary toilet, consider early
extubation if appropriate
- Appropriate oral and GI decontamination protocols
- Early and complete enteral nutrition
- Removal
of unnecessary and unessential lines/devices
- Discourage
placement of indwelling older term IV access
- Avoid
maintaining ECMO treatment for longer than necessary
- Routinely
monitor cannula insertion sites for evidence of infection
- Maintain
a low threshold to obtain cultures
Treatment:
- No
specific antibiotic recommendations, prophylactic antibiotics are discouraged
- If
antibiotics are used, ensure therapeutic levels
- The
choice of antibiotics for infections are unrelated to ECMO, unless a silicone
membrane is in use
- Complete
the treatment of pre-ECMO infections
- For
presumed sepsis in patients on ECMO, refer to the ELSO database
- Persistently
positive blood cultures should encourage investigation of “hidden” abscesses
and raise consideration of changing the ECMO circuit
Resources
Abrams, D., Grasselli, G., Schmidt, M., Mueller, T., & Brodie, D. (2020). ECLS-associated infections in adults: what we know and what we don’t yet know. Intensive Care Medicine, 46(2), 182–191. https://doi.org/10.1007/s00134-019-05847-z
Biffi, S., Di Bella, S., Scaravilli, V., Peri, A. M., Grasselli, G., Alagna, L., Pesenti, A., & Gori, A. (2017). Infections during extracorporeal membrane oxygenation: epidemiology, risk factors, pathogenesis and prevention. International Journal of Antimicrobial Agents, 50(1), 9–16. https://doi.org/https://doi.org/10.1016/j.ijantimicag.2017.02.025
Extracorporeal Life Support Organization. (2008). Infection Control and Extracorporeal Life Support.
A Jason Johnson is a doctoral student and graduate assistant
in the School of Public and Population Health.
B